Statera Biopharma, Inc.
STAB
$0.0001
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -3.35M | -3.49M | -7.76M | -77.24M | -12.72M |
| Total Depreciation and Amortization | 191.80K | 131.10K | 120.20K | 113.30K | 139.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -652.90K | -714.00K | 450.90K | 65.92M | 1.69M |
| Change in Net Operating Assets | 3.01M | 3.90M | 3.42M | 3.85M | -4.33M |
| Cash from Operations | -801.50K | -168.50K | -3.76M | -7.36M | -15.22M |
| Capital Expenditure | 0.00 | 0.00 | -6.50K | -96.90K | -63.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 13.11M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -6.50K | -96.90K | 13.04M |
| Total Debt Issued | 0.00 | 500.00K | -- | 0.00 | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -9.30M | -800.00K | -97.70K |
| Issuance of Common Stock | 711.70K | 51.30K | 6.46M | 889.50K | 6.45M |
| Repurchase of Common Stock | -- | -51.30K | -51.30K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -5.69M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00 | -100.00 | 0.00 | 0.00 |
| Cash from Financing | 711.70K | 500.10K | -2.90M | 89.40K | 671.80K |
| Foreign Exchange rate Adjustments | 42.20K | 69.90K | -26.10K | -4.70K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.70K | 401.60K | -6.69M | -7.37M | -1.51M |